Mujuan Xu
Shenzhen, 518000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Tanshinone IIA Ameliorates Heart Failure by Inhibiting Ferroptosis via the Sirt1/p53/GPX4 Signaling Pathway.
Journal: The American journal of Chinese medicine
Published: July 08, 2026
Ginsenoside Rg3 attenuates myocardial ischemia/reperfusion-induced ferroptosis via the keap1/Nrf2/GPX4 signaling pathway.
Journal: BMC complementary medicine and therapies
Published: January 12, 2024
LIMD2 is the Signature of Cell Aging-immune/Inflammation in Acute Myocardial Infarction.
Journal: Current medicinal chemistry
Published: August 09, 2023
Mechanism of angiotensin-converting enzyme inhibitors in the treatment of dilated cardiomyopathy based on a protein interaction network and molecular docking.
Journal: Cardiovascular diagnosis and therapy
Published: March 14, 2023
The effects of Xuebijing injection combined with ulinastatin as adjunctive therapy on sepsis: An overview of systematic review and meta-analysis.
Journal: Medicine
Published: October 25, 2022
Efficacy and safety of Shengmai injection as an adjunctive therapy on sepsis: A protocol for systematic review and meta-analysis.
Journal: Medicine
Published: December 10, 2021
Effect of Sini decoction on function of hypothalamic-pituitary-adrenal axis in patients with sepsis
Journal: Zhonghua wei zhong bing ji jiu yi xue
Published: March 07, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026